How are Genotypes Connected to Phenotypes?

Why Is This Concept Necessary?

NGS can identify a large number of variants in an individual. However, the mere discovery of a variant does not justify the conclusion that the variant explains the patient’s current symptoms or disease.

The central question in clinical interpretation is:

Does this genetic change have evidence linking it to the observed phenotype in this individual?

The genotype refers to the variant and the state of the gene, while the phenotype denotes observable characteristics such as signs, symptoms, test results, and patterns of disease onset. Genotype–phenotype correlation is not merely a table that maps variants to phenotypes; rather, it is a process that integrates multiple lines of evidence to assess the strength of the association and its uncertainty.

Core Concepts — The Variant List Is Not the Same as Clinical Implications

NGS results may contain numerous candidate variants depending on the analysis targets and quality. Only a subset of these is likely to be associated with the current clinical condition, and their relevance must satisfy the following questions:

• What is the functional relationship between this variant and its corresponding gene?
• What disease or phenotype is that gene associated with?
• Does the patient’s phenotype fall within the known spectrum of that disease?
• Is the mode of inheritance and pattern of transmission within the family consistent?
• Are there other independent sources of evidence supporting pathogenicity?

Therefore, variant interpretation is not a linear progression from variant detected to disease diagnosed.

variant detected
       ↓
variant / gene / disease evidence
       ↓
phenotype and inheritance comparison
       ↓
integrated classification
       ↓
clinical interpretation with uncertainty

Within this workflow, variant pathogenicity, gene–disease validity, patient phenotype concordance, and clinical actionability represent distinct layers of assessment. Support at an earlier stage does not automatically confirm subsequent stages.

How to Read Evidence Together

Phenotypic Quality

Information stating merely that "symptoms are present" may be insufficient. The strength of the connection between a genotype and phenotype varies depending on when symptoms began, how they were confirmed via testing, and whether characteristic combinations exist. Ambiguous phenotypic records can lead to inconsistent interpretations of the same variant.

Mode of Inheritance and Family Information

The mode of inheritance—such as autosomal dominant, autosomal recessive, or X-linked—alters the interpretive scope for a variant. While observing how a variant segregates within family testing can provide critical clues, it is difficult to use as standalone evidence when family sizes are small or information is incomplete.

Allele Frequency

When considering disease prevalence and the mode of inheritance, how common a variant is in general populations affects its interpretation. However, rarity alone does not prove pathogenicity.

Functional, Segregation, and Computational Evidence

Experimental functional data, intra-familial co-segregation, computational predictions, and existing literature represent distinct categories of evidence. Because each has different strengths and conditions of applicability, one must disentangle which specific evidence supports which aspect of the case rather than vaguely grouping them as "abundant evidence."

A Small Thought Experiment

Suppose a rare variant in the gene GENE-X was identified through NGS analysis of a patient’s sample. In this scenario, the following three circumstances lead to distinct interpretations:

The content of this table does not represent automated classification rules. Actual variant classification depends on guidelines specific to the variant type, associated disorder, and gene, as well as the quality of the available evidence.

Common Points of Confusion

Does the presence of a variant imply that it is the cause of the disease?

No. Variants represent observed genetic differences, whereas pathogenicity is a classification judgment based on the synthesis of multiple lines of evidence. There is an interpretive step between the mere presence of a variant and its designation as a disease cause.

Does a mismatch between phenotype and genotype mean the genotype is incorrect?

Not necessarily. Phenotypic records may be incomplete, or phenotypic expression may vary due to penetrance, expressivity, age dependence, and genetic background. However, such discordances must not be concealed; they should be documented as sources of interpretive uncertainty.

Can a single ACMG/AMP criterion allow for uniform interpretation across all genes?

While the ACMG/AMP framework provides a common foundation, its practical application often requires variant-type- and gene/disease-specific specifications. Therefore, one should consult ClinGen’s gene- and disease-specific guidance alongside the most current resources.

Current Evidence and Limitations

• The genotype–phenotype relationship can serve as an important context for clinical interpretation.
• Variant classification is a process that integrates multiple lines of evidence with clinical context.
• This document excludes specific disease–variant cases whose primary evidence has not been independently validated.
• To determine the diagnostic or therapeutic implications of a particular variant, it is necessary to consult the relevant primary literature and the latest gene/disease-specific guidelines separately.

Connection Concept / Story

• Concept: variant interpretation, inheritance, phenotype quality, population frequency
• Potential Story: The process of narrowing down genomic information to address a clinical question in a specific patient case

References

• ACMG/AMP sequence variant guideline
• ClinGen variant classification guidance
• ClinGen Gene–Disease Validity
• ClinGen Gene–Disease Validity SOP v12
• ClinGen Gene–Disease Validity SOP